December 9, 2013
An FDA panel is expected to decide Wednesday if the diabetes drug Avandia should stay on the market.
Government experts are trying to determine if the once popular drug can increase the risk of heart attack.
The panel could recommend putting more warning labels on Avandia or pulling it.
The FDA usually follows recommendations from the advisory committee.
|Get the ingredients you need to cook with Rach all week long.|
|Full length exclusive concerts from hot artists.|
|Take a break!
Classic Pacman, Frogger, Asteroids and more.
Sell almost anything locally.